Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial
New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds
Docetaxel As Adjuvant Therapy Shows Benefit Over Standard
QOL Of Anemic Patients Improved With Darbepoetin
UC Davis Study Finds Patients Need Practical Information
Clinical Trials Approved By NCI CTEP During May
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore









